Sunshine Heart Announces Presentations at 2014 International Society for Heart and Lung Transplantation Meeting
GlobeNewswire - Thu Apr 03, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that its flagship C-Pulse(R) Heart Assist System will be the subject of presentations at The International Society for Heart and Lung Transplantation (ISHLT) 34th Annual Meeting and Scientific Sessions, April 10-13 at the Manchester Grand Hyatt in San Diego, CA.
Nasdaq stocks posting largest percentage increases
AP - Tue Mar 18, 12:44PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Why Sunshine Heart (SSH) Is Plunging Today
at The Street - Tue Mar 11, 1:19PM CDT
Sunshine Heart (SSH) plunges after the company, known for its C-Pulse Heart Assist System to treat moderate to severe heart failure, reported a fourth-quarter loss per share that was wider than analysts' expectations and also provided a discouraging...
Sunshine Heart Announces Fourth Quarter and Full-Year 2013 Financial Results and Corporate Update
GlobeNewswire - Tue Mar 11, 4:15AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) today announced its financial results and provided a corporate update for the fourth quarter and full-year ended December 31, 2013.
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Fri Feb 28, 2:54PM CST
Sunshine Heart, Inc. (Nasdaq:SSH), today announced that on February 27, 2014, the Compensation Committee of its Board of Directors approved eleven equity awards under Sunshine Heart's New-Hire Equity Incentive Plan, as material inducements to eleven individuals' entering into employment with the Company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
Sunshine Heart to Release Fourth Quarter and Year-End 2013 Results on March 11, 2014
GlobeNewswire - Wed Feb 26, 11:28AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that its fourth quarter and year-end 2013 results will be released on Tuesday, March 11, 2014, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
Sunshine Heart to Attend Upcoming Investor Conferences
GlobeNewswire - Wed Feb 26, 4:15AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that the company is scheduled to present a corporate update at the following upcoming investor conferences in March, 2014:
Sunshine Heart to Appear on Bloomberg Television's Taking Stock
GlobeNewswire - Wed Feb 05, 4:15AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that Chief Executive Officer, Dave Rosa, will be featured on Bloomberg Television's Taking Stock on Wednesday, February 5, 2014 at 5:00 pm EST. Hosted by Bloomberg anchor Pimm Fox, Taking Stock is a daily investment-focused program featuring conversations with leading Wall Street analysts, fund managers and CEOs, offering insight into company news, market and trading strategies across equities, fixed income, commodities, and currencies. Following the segment, a link to a recording of the program will be posted to the investor page of Sunshine Heart's website at: http://ir.sunshineheart.com.
Sunshine Heart Provides Corporate Update
GlobeNewswire - Mon Jan 13, 4:15AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today provided a corporate update in advance of the 2014 J.P. Morgan Healthcare Conference, taking place January 13 through 17 in San Francisco.
New Ideas Offer Hope for Both Heart Failure Patients and Investors
Stephen D., Simpson,, The Motley Fool - Motley Fool - Mon Dec 16, 1:55PM CST
Steep valuations and uncertainty about adoption have created a lot of volatility in the shares of HeartWare International and Thoratec , the leading developers of ventricular assist devices or VADs that help seriously ill heart failure patients...
Sunshine Heart Announces Third Quarter 2013 Financial Results and Corporate Update
GlobeNewswire - Mon Nov 11, 4:15AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced financial results and provided a corporate update for the third quarter ended September 30, 2013.
Sunshine Heart to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Nov 06, 4:15AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced that the company is scheduled to present a corporate update at the following upcoming investor conferences for the balance of 2013:
Sunshine Heart to Provide Summary of Initial OPTIONS HF Data and Additional Clinical Updates at 2013 Transcatheter Cardiovascular Therapeutics Analyst Event
GlobeNewswire - Tue Oct 29, 9:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that the initial C-Pulse System patient data of its ongoing OPTIONS HF EU trial, will be presented by Professor Thomas Krabatsch, Director of Mechanical Circulatory Support at the German Heart Institute, Berlin to the investment community at Sunshine Heart's third annual analyst breakfast event, held this morning at 7:30 a.m. PDT at the W Hotel San Francisco. As announced on October 22, 2013, the event also includes presentations from Dr. Andrew Kao, Associate Professor of Medicine at the University of Missouri-Kansas City; as well as Dr. William Cohn, Director of Minimally Invasive Surgical Technology of Texas Heart Institute. Following the event, the presentations and audio will be available on the investor section of the Sunshine Heart website at: http://ir.sunshineheart.com/index.cfm.
Sunshine Heart to Feature Initial European OPTIONS HF Data at 2013 Transcatheter Cardiovascular Therapeutics Conference
GlobeNewswire - Tue Oct 22, 4:15AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its flagship C-Pulse Heart Assist System will be featured in a clinical presentation at the 25 annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The TCT symposium will take place October 27 through November 1 in San Francisco, CA at the Moscone Center.
Nasdaq stocks posting largest volume increases
AP - Thu Sep 19, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Sunshine Heart prices 3.8M shares at $10.50 each
AP - Thu Sep 19, 3:03PM CDT
EDEN PRAIRIE, Minn. (AP) — Sunshine Heart Inc., which makes medical devices to treat heart failure, said Thursday that it priced its stock offering of 3.8 million shares at $10.50 each. The company expects about $37 million in proceeds after expenses.
Sunshine Heart, Inc. Prices $40.0 Million Public Offering of Common Shares
GlobeNewswire - Thu Sep 19, 8:23AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today the pricing of its previously announced offering of 3,810,000 shares of its common stock at a price to the public of $10.50 per share in an underwritten public offering pursuant to its effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission (SEC). Piper Jaffray & Co. and Cowen and Company, LLC are acting as joint book-running managers and Lazard Capital Markets LLC is acting as co-lead manager for the offering. Craig-Hallum Capital Group and Northland Securities, Inc. are acting as co-managers for the offering. In addition, Sunshine Heart has granted the underwriters a 30-day option to purchase up to an additional 571,500 shares solely to cover over-allotments, if any. The offering is expected to close on or about September 24, 2013, subject to customary closing conditions.